Impact of abrocitinib on itch, sleep, skin pain and psychological stress in patients with moderate-to-severe atopic dermatitis: pooled analysis from JADE monotherapy trials

被引：0
|
作者：
Bewley, A. [1 ]
Thyssen, J. P. [2 ]
Chiu, W. S. [3 ]
Rojo, R. [4 ]
Biswas, P. [5 ]
Feeney, C. [3 ]
DiBonaventura, M. [5 ]
Misery, L. [6 ]
Stander, S. [7 ]
Cork, M. [8 ]
机构：
[1] Barts Hlth NHS Trust, London, England
[2] Univ Copenhagen, Copenhagen, Denmark
[3] Pfizer Ltd, Tadworth, England
[4] Pfizer Inc, Groton, CT 06340 USA
[5] Pfizer Inc, New York, NY USA
[6] Univ Hosp Ctr Brest, Brest, France
[7] Muenster Univ Hosp, Munster, Germany
[8] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 185卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
B06
引用
收藏
页码：E72 / E73
页数：2
相关论文
共 50 条
  • [41] Skin infections during dupilumab monotherapy in moderate-to-severe atopic dermatitis - a meta-analysis of randomized clinical trials
    Marko, Monika
    Pawliczak, Rafal
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (01) : 121 - 134
  • [42] Abrocitinib improves work productivity through improvement in pruritus and sleep: Results from the JADE MONO-2 study in patients with moderate-to-severe atopic dermatitis (AD)
    Yosipovitch, Gil
    Deleuran, Mette
    Su, John
    Fonacier, Luz
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Feeney, Claire
    Thorpe, Andrew
    Rojo, Ricardo
    Valdez, Hernan
    Myers, Daniela E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB153 - AB153
  • [43] Efficacy and safety of abrocitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
    Meher, Bikash Ranjan
    Mohanty, Rashmi Ranjan
    Padhy, Biswa Mohan
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2335 - 2343
  • [44] Long-term efficacy of abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis: a post hoc analysis of JADE EXTEND
    Paller, Amy S.
    Cork, Michael J.
    Flohr, Carsten
    Bangert, Christine
    Weidinger, Stephan
    Nesnas, John
    Farooqui, Saleem A.
    Biswas, Pinaki
    Watkins, Melissa
    Koppensteiner, Herwig
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [45] Lebrikizumab improvement in itch reduction at 52 weeks in patients with moderate-to-severe atopic dermatitis: pooled analysis of two phase 3 randomized controlled trials
    Yosipovitch, Gil
    Lio, Peter
    Rosmarin, David
    Legat, Franz
    Carrascosa, Jose Manuel
    Meskimen, Eric
    Casillas, Marta
    Pierce, Evangeline
    Liu, Zhuqing
    Zhong, Jinglin
    Staender, Sonja
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB188 - AB188
  • [46] Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)
    Shi, Vivian Y.
    Bhutani, Tina
    Fonacier, Luz
    Deleuran, Mette
    Shumack, Stephen
    Valdez, Hernan
    Zhang, Fan
    Chan, Gary L.
    Cameron, Michael C.
    Yin, Natalie C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (02) : 351 - 358
  • [47] Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: a post-hoc analysis of the JADE REGIMEN phase 3 trial
    Li, Hang
    Cheng, Hao
    Lu, Qianjin
    Lai, Wei
    Tao, Xiaohua
    Encinas, Gerardo A.
    Vyas, Shefali
    Wang, Bo
    Luo, Xin
    Li, Shiqi
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [48] Effectiveness and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Fadlalmola, Hammad Ali
    Albadrani, Muayad Saud
    Elhusein, Amal Mohamed
    Mohamedsalih, Wahieba E.
    Swamy, Veerabhadra D. S.
    Mamanao, Daniel Mon
    DERMATOLOGY RESEARCH AND PRACTICE, 2021, 2021
  • [49] Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes
    Silverberg, Jonathan I.
    Thyssen, Jacob P.
    Simpson, Eric L.
    Yosipovitch, Gil
    Staender, Sonja
    Valdez, Hernan
    Rojo, Ricardo
    Biswas, Pinaki
    Myers, Daniela E.
    Feeney, Claire
    DiBonaventura, Marco
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (04) : 541 - 554
  • [50] Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes
    Jonathan I. Silverberg
    Jacob P. Thyssen
    Eric L. Simpson
    Gil Yosipovitch
    Sonja Ständer
    Hernan Valdez
    Ricardo Rojo
    Pinaki Biswas
    Daniela E. Myers
    Claire Feeney
    Marco DiBonaventura
    American Journal of Clinical Dermatology, 2021, 22 : 541 - 554
12345